Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × Introns × Clear all

NCT00234182 2005-12-01

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Recurrence